Treatment with Micafungin in a Preterm Neonate with an Invasive Candida parapsilosis Infection after a Severe Terlipressin-Induced Skin Necrosis
Abstract
:1. Introduction
2. Case Description
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Kett, D.H.; Azoulay, E.; Echeverria, P.M.; Vincent, J.L. Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators. Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study. Crit. Care Med. 2011, 39, 665–670. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Warris, A.; Pana, Z.D.; Oletto, A.; Lundin, R.; Castagnola, E.; Lehrnbecher, T.; Groll, A.H.; Roilides, E.; EUROCANDY study group. Etiology and Outcome of Candidemia in Neonates and Children in Europe: An 11-year Multinational Retrospective Study. Pediatr. Infect. Dis. J. 2020, 39, 114–120. [Google Scholar] [CrossRef] [PubMed]
- Pammi, M.; Holland, L.; Butler, G.; Gacser, A.; Bliss, J.M. Candida parapsilosis is a significant neonatal pathogen: A systematic review and meta-analysis. Pediatr. Infect. Dis. J. 2013, 32, e206–e216. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Larkin, E.L.; Dharmaiah, S.; Ghannoum, M.A. Biofilms and beyond: Expanding echinocandin utility. J. Antimicrob. Chemother. 2018, 73, i73–i81. [Google Scholar] [CrossRef] [PubMed]
- Auriti, C.; Goffredo, B.M.; Ronchetti, M.P.; Piersigilli, F.; Cairoli, S.; Bersani, I.; Dotta, A.; Bagolan, P.; Pai, M.P. High-dose micafungin in neonates and young infants with invasive candidiasis: Results of a phase 2 study. Antimicrob. Agents Chemother. 2021, 65, e02494–e02520. [Google Scholar] [CrossRef] [PubMed]
- Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard, 3rd ed.; CLSI Document M27-A3; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2008. [Google Scholar]
- Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; 4th Informational Supplement; CLSI Document; M27-S4 Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2012. [Google Scholar]
- De Rose, D.U.; Cairoli, S.; Dionisi, M.; Santisi, A.; Massenzi, L.; Goffredo, B.M.; Dionisi-Vici, C.; Dotta, A.; Auriti, C. Therapeutic Drug Monitoring Is a Feasible Tool to Personalize Drug Administration in Neonates Using New Techniques: An Overview on the Pharmacokinetics and Pharmacodynamics in Neonatal Age. Int. J. Mol. Sci. 2020, 21, 5898. [Google Scholar] [CrossRef] [PubMed]
- Estivill, D.; Arias, A.; Torres-Lana, A.; Carrillo-Muñoz, A.J.; Arévalo, M.P. Biofilm formation by five species of Candida on three clinical materials. J. Microbiol. Methods. 2011. [Google Scholar] [CrossRef] [PubMed]
- Greenberg, R.G.; Benjamin, D.K., Jr.; Gantz, M.G.; Cotten, C.M.; Stoll, B.J.; Walsh, M.C.; Sánchez, P.J.; Shankaran, S.; Das, A.; Higgins, R.D.; et al. Empiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis. J. Pediatr. 2012, 161, 264–269.e2. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Steinbach, W.J.; Roilides, E.; Berman, D.; Hoffman, J.A.; Groll, A.H.; Bin-Hussain, I.; Palazzi, D.L.; Castagnola, E.; Halasa, N.; Velegraki, A.; et al. Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr. Infect. Dis. J. 2012, 31, 1252–1257. [Google Scholar] [CrossRef] [PubMed]
- Khodavaisy, S.; Badali, H.; Meis, J.F.; Modiri, M.; Mahmoudi, S.; Abtahi, H.; Salehi, M.; Manshadi, S.A.D.; Aala, F.; Afshari, S.A.K.; et al. Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex. J. Mycol. Med. 2020, 30, 100968. [Google Scholar] [CrossRef] [PubMed]
- Lindberg, E.; Hammarström, H.; Ataollahy, N.; Kondori, N. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia. Sci. Rep. 2019, 9, 3838. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yanni, S.B.; Smith, P.B.; Benjamin, D.K., Jr.; Augustijns, P.F.; Thakker, D.R.; Annaert, P.P. Higher clearance of micafungin in neonates compared with adults: Role of age-dependent micafungin serum binding. Biopharm. Drug Dispos. 2011, 32, 222–232. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Smith, P.B.; Walsh, T.J.; Hope, W.; Arrieta, A.; Takada, A.; Kovanda, L.L.; Kearns, G.L.; Kaufman, D.; Sawamoto, T.; Buell, D.N.; et al. Pharmacokinetics of an elevated dosage of micafungin in premature neonates. Pediatr. Infect. Dis. J. 2009, 28, 412–415. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Benjamin, D.K., Jr.; Smith, P.B.; Arrieta, A.; Castro, L.; Sánchez, P.J.; Kaufman, D.; Arnold, L.J.; Kovanda, L.L.; Sawamoto, T.; Buell, D.N.; et al. Safety and pharmacokinetics of repeat-dose micafungin in young infants. Clin. Pharmacol. Ther. 2010, 87, 93–99. [Google Scholar] [CrossRef] [PubMed]
- Auriti, C.; Falcone, M.; Ronchetti, M.P.; Goffredo, B.M.; Cairoli, S.; Crisafulli, R.; Piersigilli, F.; Corsetti, T.; Dotta, A.; Pai, M.P. High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis. Antimicrob. Agents Chemother. 2016, 60, 7333–7339. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shivanna, B.; Rios, D.; Rossano, J.; Fernandes, C.J.; Pammi, M. Vasopressin and its analogues for the treatment of refractory hypotension in neonates. Cochrane Database Syst. Rev. 2013, 3, CD009171. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mégarbané, H.; Barete, S.; Khosrotehrani, K.; Izzedine, H.; Moguelet, P.; Chosidow, O.; Frances, C.; Aractingi, S. Two observations raising questions about risk factors of cutaneous necrosis induced byterlipressin (Glypressin). Dermatology 2009, 218, 334–337. [Google Scholar] [CrossRef] [PubMed]
- Yefet, E.; Gershovich, M.; Farber, E.; Soboh, S. Extensive epidermal necrosis due to terlipressin. Isr. Med. Assoc. J. 2011, 13, 180–181. [Google Scholar] [PubMed]
- Coskun, B.D.O.; Karaman, A.; Gorkem, H.; Buğday, I.; Poyrazoğlu, O.K.; Senel, F. Terlipressin-induced ischemic skin necrosis: A rare association. Am. J. Case Rep. 2014, 15, 476–479. [Google Scholar] [CrossRef] [Green Version]
- Rodríguez-Núñez, A.; Oulego-Erroz, I.; Gil-Antón, J.; Pérez-Caballero, C.; López-Herce, J.; Gaboli, M.; Milano, G.; RETSPED-II Working Group of the Spanish Society of Pediatric Intensive Care. Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock. Ann. Pharmacother. 2010, 44, 1545–1553. [Google Scholar] [CrossRef] [PubMed]
Dose (Over 24 h) | Site | 30 min before Infusion | 1 h after Infusion | 2 h after Infusion | 8 h after Infusion |
---|---|---|---|---|---|
8 mg/kg | Plasma | 3.73 | 11.79 | 9.70 | 7.9 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
De Rose, D.U.; Piersigilli, F.; Goffredo, B.M.; Danhaive, O.; Dotta, A.; Auriti, C. Treatment with Micafungin in a Preterm Neonate with an Invasive Candida parapsilosis Infection after a Severe Terlipressin-Induced Skin Necrosis. Pathogens 2021, 10, 890. https://doi.org/10.3390/pathogens10070890
De Rose DU, Piersigilli F, Goffredo BM, Danhaive O, Dotta A, Auriti C. Treatment with Micafungin in a Preterm Neonate with an Invasive Candida parapsilosis Infection after a Severe Terlipressin-Induced Skin Necrosis. Pathogens. 2021; 10(7):890. https://doi.org/10.3390/pathogens10070890
Chicago/Turabian StyleDe Rose, Domenico Umberto, Fiammetta Piersigilli, Bianca Maria Goffredo, Olivier Danhaive, Andrea Dotta, and Cinzia Auriti. 2021. "Treatment with Micafungin in a Preterm Neonate with an Invasive Candida parapsilosis Infection after a Severe Terlipressin-Induced Skin Necrosis" Pathogens 10, no. 7: 890. https://doi.org/10.3390/pathogens10070890
APA StyleDe Rose, D. U., Piersigilli, F., Goffredo, B. M., Danhaive, O., Dotta, A., & Auriti, C. (2021). Treatment with Micafungin in a Preterm Neonate with an Invasive Candida parapsilosis Infection after a Severe Terlipressin-Induced Skin Necrosis. Pathogens, 10(7), 890. https://doi.org/10.3390/pathogens10070890